Wu et al (146) found that ALKBH5 removes m6A modification to stabilize BRCA1 (DNA repair protein) mRNA, further enhance its DNA repair ability and increase the resistance of BC cells to doxorubicin. This evidence concerns the gene BRCA1 and breast cancer.